Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction

By Hayashi M.   Tsutamoto T.   Wada A.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 16-17

Elsevier

Access to resources Recommend Favorite

Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism

By  

Current Hypertension Reviews, Vol. 13, Iss. 1, 2017-06 ,pp. : 46-56

Bentham Science Publishers

Access to resources Recommend Favorite

Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade

By Funder John W  

Future Cardiology, Vol. 2, Iss. 5, 2006-09 ,pp. : 535-541

Future Medicine

Access to resources Recommend Favorite

Efficacy and Safety of a New Streptokinase Regimen with Enoxaparin in Acute Myocardial Infarction

By Tatu-Chitoiu Gabriel   Teodorescu Cristina   Dan Monica   Capraru Petre   Guran Manuela   Istratescu Oana   Tatu-Chitoiu Alexandrina   Bumbu Aurelia   Dorobantu Maria  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 3, 2003-06 ,pp. : 171-179

Springer Publishing Company

Access to resources Recommend Favorite

The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Trial

By Callas Ph.D. P.W.   Tracy Ph.D. R.P.   Bovill M.D. E.G.   Cannon M.D. C.   Thompson Ph.D. B.   Mann Ph.D. K.G.  

Journal of Thrombosis and Thrombolysis, Vol. 5, Iss. 1, 1998-01 ,pp. : 53-60

Springer Publishing Company

Access to resources Recommend Favorite